Breast cancer research in 2026 focuses on precision medicine — matching treatments to your tumor's specific molecular profile. Antibody-drug conjugates (ADCs) like trastuzumab deruxtecan are being studied in expanded populations. Immunotherapy combinations with checkpoint inhibitors show promise for triple-negative breast cancer. CDK4/6 inhibitor trials explore new combinations for hormone-receptor-positive disease. Neoadjuvant studies test whether giving treatment before surgery improves outcomes. Trials are available for early-stage, locally advanced, and metastatic breast cancer at sites nationwide. Whether you are newly diagnosed or managing recurrent disease, clinical trials can offer access to cutting-edge treatments.
Cancer
Breast Cancer Clinical Trials: New Treatment Options
Quick Answer
Dozens of breast cancer clinical trials are recruiting now, testing targeted therapies, immunotherapy combinations, antibody-drug conjugates, and personalized treatment plans based on tumor genetics and biomarkers.
Take the Next Step
Find clinical trials that match your condition, location, and treatment preferences.